Study of Natalizumab in Relapsed/Refractory Multiple Myeloma

NCT00675428 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision due to low enrollment and not safety concerns.

Conditions

Interventions

Sponsor

Biogen